Romuvos klinika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 185,037 | 214,273 | 297,657 | 490,779 | 652,643 | 761,829 | 757,775 | 752,552 |
| Profit before tax | 54,662 | 30,797 | 71,817 | -6,235 | -7,692 | -6,115 | 396 | 23,886 |
| Net profit | 45,638 | 25,861 | 61,881 | -6,235 | -7,692 | -6,115 | 330 | 21,285 |
| Equity | 52,005 | 32,666 | 69,551 | 24,316 | 16,624 | 10,508 | 10,838 | 32,123 |
| Liabilities | 14,930 | 6,077 | 11,156 | 39,858 | 50,452 | 53,081 | 45,325 | 56,388 |
| Non-current assets | 2,356 | 2,256 | 3,264 | 3,870 | 3,302 | 1,881 | 1,017 | 705 |
| Current assets | 63,757 | 35,024 | 74,725 | 58,621 | 61,894 | 59,889 | 60,695 | 107,314 |
| Total assets | 66,113 | 37,280 | 77,989 | 62,491 | 65,196 | 61,770 | 61,712 | 108,019 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 124,328 | 133,846 | 119,840 |
| Social insurance contributions | - | - | - | - | - | 152,305 | 151,770 | 142,261 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +38.0% | +15.8% | +38.9% | +64.9% | +33.0% | +16.7% | -0.5% | -0.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 69.0% | 69.4% | 79.3% | -10.0% | -11.8% | -9.9% | 0.5% | 19.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 87.8% | 79.2% | 89.0% | -25.6% | -46.3% | -58.2% | 3.0% | 66.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 24.7% | 12.1% | 20.8% | -1.3% | -1.2% | -0.8% | 0.0% | 2.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 29.5% | 14.4% | 24.1% | -1.3% | -1.2% | -0.8% | 0.1% | 3.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.2 | 0.2 | 1.6 | 3.0 | 5.1 | 4.2 | 1.8 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 9,489 | 9,419 | 12,622 | 18,578 | 21,635 | 23,807 | 21,964 | 22,243 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Romuvos klinika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-02-10 | 2025-02-10 | 0.11 |
| 2025-01-22 | 2025-02-06 | 0.11 |
| 2024-11-18 | 2024-11-20 | 85.84 |
| 2023-02-17 | 2023-03-07 | 0.08 |
| 2023-02-06 | 2023-02-09 | 0.14 |
| 2023-01-23 | 2023-02-03 | 0.14 |
| 2022-11-17 | 2022-11-18 | 89.34 |
Romuvos klinika - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Romuvos klinika, UAB (code 302972997) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of €752.6K and net profit of €21.3K, giving a profit margin of 2.8%. Revenue was slightly lower than in 2024, when it reached €757.8K, and also below the 2023 level of €761.8K, so the top line has been broadly stable with a mild downward trend over the last two years. Profitability improved materially over the same period: the company moved from a net loss of €6.1K in 2023 to a small profit of €330 in 2024 and a stronger result in 2025. At the end of 2025, total assets stood at €108.0K, equity at €32.1K, and liabilities at €56.4K. The balance sheet expanded significantly compared with 2023 and 2024, when assets were about €61.7K-€61.8K. Key ratios indicate efficient asset use, with asset turnover of 6.97x, and a leveraged but still positive capital structure, reflected in a debt-to-equity ratio of 1.76 and an equity ratio of 29.7%. Revenue per employee was €22.8K.